We used CRISPR-Cas9 in the staple food crop cassava with the aim of engineering resistance to African cassava mosaic virus, a member of a widespread and important family of plant-pathogenic DNA viruses. We found that between 33 and 48% of edited virus genomes evolved a conserved single-nucleotide mutation that confers resistance to CRISPR-Cas9 cleavage. Our study highlights the potential for virus escape from this technology. Care should be taken to design CRISPR-Cas9 experiments that minimize the risk of virus escape.
The bacterial CRISPR-Cas9 (Clustered, regularly interspaced short palindromic repeats-CRISPR associated 9) gene editing system can be used to engineer resistance to DNA viruses through direct cleavage of the virus genome. Unlike conventional gene-editing using CRISPRCas9, engineering virus resistance requires constitutive and permanent expression of the ribonucleoprotein complex in the host. For example, CRISPR/Cas9 system has been used to engineer immunity to latent HIV-1 proviruses, Hepatitis B viruses, Herpes simplex virus and the Human papillomavirus in mammalian cell lines 1 . CRISPR-Cas9 has also been used in the model plants Arabidopsis thaliana and Nicotiana benthamiana to engineer resistance to ssDNA geminiviruses [2] [3] [4] . However, the degree to which using CRISPR-Cas9 to engineer virus-resistance results in the evolution of resistant viruses is unknown. One concern (which has previously been highlighted 5 ) might be that planting transgenic, virus-resistant CRISPR-Cas9 plants in the field will impose a selection pressure on viruses, while simultaneously providing viruses with a mechanism (via Cas9-induced mutations) to escape resistance. We applied CRISPR-Cas9 to engineer resistance to geminiviruses in cassava and investigated the impact of engineering resistance on geminivirus evolution. We failed to engineer geminivirus resistance, but, we found that use of CRISPR-Cas9 led to emergence of a novel, conserved mutant virus that cannot be cleaved again. We urge caution in the application of CRISPR-Cas9 for virus resistance in plants, both in glasshouse and field settings, to prevent the evolution of novel viruses.
Cassava is a tropical staple food crop consumed by more than a billion people. Cassava production in Africa and South Asia can be decimated by cassava mosaic geminiviruses 6 . Biotechnology has proven effective for engineering cassava mosaic virus resistance by using plant endogenous RNA interference (RNAi) pathways to limit the expression of virus genes 7 . However, the fact that plant viruses have developed effective suppressors of RNAi 8 , as well as the limited success of RNAi-mediated geminivirus resistance suggest that newer methods of engineering resistance are needed. Using orthogonal systems like CRISPR-Cas9 to which plant viruses are unlikely to have developed suppressing mechanisms hence appears particularly attractive.
We designed a set of single-guide RNAs (sgRNAs) using a custom algorithm that combines knowledge about potential off-target effects with published software predicting sgRNA template-cleaving efficiency 9 . We chose sgRNA1, which targets both the viral AC2 gene coding for the multifunctional TrAP protein involved in gene activation, virus pathogenicity and suppression of gene silencing, and the AC3 gene coding for the REn protein involved in replication enhancement 10 ( Supplementary Fig. 1 a, b) . Selected independent transgenic lines (7 Cas9+sgRNA1, 2 control Cas9-only lines, and wild-type controls (WT)) were tested for transgene expression in vitro ( Supplementary Fig. 1 c, d ) and virus resistance in the greenhouse using an infectious clone of ACMV that was introduced using Agrobacterium tumefaciens 7 . No significant differences in disease incidence, symptom severity or virus titres were found between test and control lines ( Supplementary Fig. 2 a-c) .
In order to better understand why we couldn't detect resistance, we sequenced full-length viral amplicons from pooled infected samples at 3 and 8 weeks post-infection (wpi) using Single Molecule Real Time (SMRT) sequencing with a minimum depth of 100 full-length, high quality virus genomes per plant. We chose to sequence the whole viral genome in order to check Cas9+sgRNA1 mediated editing of the targeted viral sequences as well as any other targets. A total of 4942 full-length virus genome sequences were analyzed by alignment against the intact wild-type ACMV genome sequence. We detected CRISPR-edited virus sequences in 3 Cas9+sgRNA1 lines at 8wpi, with line 118 having the highest proportion of edited virus sequences (11%) (Fig. 1 a, Supplementary Fig. 2 d,e, Supplementary Fig. 3 ). We analysed the AC2 and AC3 genes in depth because these were meant to be edited in Cas9+sgRNA1 lines ( Supplementary  Fig. 4 Supplementary Fig. 4 ). We analyzed the predicted AC2 and AC3 proteins in all sequenced viruses from all of the cassava lines (density plots, Supplementary Fig. 4 & 5) . These data indicate that the Cas9+sgRNA1 118 line (and to a lesser extent lines 130 and 139) contain viruses with the desired edits, where the AC2 and AC3 open reading frames stop prematurely at the sgRNA target site. We also detected indels that were present in viruses infecting all plants including controls (minor peaks, Supplementary Fig. 4 & 5, and mismatches, Fig. 1a & Supplementary Fig. 3 ). These mutations are likely to represent naturally occurring viral variants in our experiment.
While studying the CRISPR-Cas9 caused amino acid substitutions in our entire dataset single-nucleotide insertion in the AC2 open-reading frame we identified a conserved singlenucleotide insertion in the AC2 open-reading frame ( Fig. 1 b-e) . Interestingly this conserved mutation was found in three independent Cas9+sgRNA1 lines (but not in any of our 3 control lines). In each of these lines, this virus variant (named ACMV-AC2 H54Q) comprised between 33-48% of all mutant viruses per line, which might indicate selection for this conserved mutation (Fig.  1c) . In ACMV-AC2 H54Q the single nucleotide 'T' insertion ( Fig. 1d ) results in a H54Q substitution in the AC2 gene and production of a premature stop codon, reducing the length of the AC2 protein from 136AA to 62AA. However, this mutation also creates a new ORF, which might code for the missing AC2 residues. Thus, in this viral variant (Supplementary Data 1) , the Cas9-mediated edit at the target site generates two distinct translational units for AC2 (Fig. 1e) . Owing to genome organization in cassava geminivirus, the AC3 start codon is disrupted by the AC2 H54Q mutation, and the AC3 open reading frame starts at the next ATG, which might result in a truncated 120 AA protein (Fig. 1e) . Interestingly the single 'T' insertion in ACMV-AC2 H54Q is in the sgRNA seed sequence. This means that the insertion that is selected for during editing makes ACMV-AC2 H54Q resistant to further cleavage using sgRNA1, as validated using an in vitro cleavage assay (Supplementary Fig. 6 ).
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In our experiment, CRISPR-Cas9 mediated interference of ACMV in cassava transgenic lines resulted in selection for a conserved, abundant, cleavage-resistant mutant virus. We did not observe a clear disease-resistance phenotype associated with the implementation of an CRISPRCas9 sgRNA1 virus interference system. Bacteria and archaea use the CRISPR system to defend against viruses and plasmids, but DNA repair mechanisms differ substantially in bacteria and archaea compared with eukaryotes. Most bacteria lack non-homologous end joining (NHEJ) as a DNA-repair mechanism 11 and cleaved phage/plasmid DNA is usually degraded rather than repaired 12, 13 . In eukaryotes NHEJ enables efficient genome editing by effectively repairing cleaved DNA. However, this efficient repair mechanism makes CRISPR-Cas9 mediated virus resistance more prone to evolving mutant viruses. We detected numerous CRISPR-edited viruses whose sequence suggests that dsDNA replicative forms of these viruses have been repaired by NHEJ post-cleavage. Repaired viral genomes have been detected previously in two earlier studies in stable transgenic plants 2, 3 , as well as in a study with a viral-vector delivered CRISPR-Cas9 system in model plants 4 and studies aimed at engineering virus resistance in mammalian systems 14, 15 . Although evolution of stable CRISPR-Cas9 cleavage-resistant viruses in plants has been predicted 5 we now provide confirmation of this in a crop plant. One additional consideration in experiments to engineer virus resistance in eukaryotes is the monitoring period, which in this study was twice as long as in previous studies 2, 3 . We first detected ACMV-AC2 H54Q at 8wpi, suggesting that evolution of resistant viruses may occur later in the infection process.
We found that using CRISPR-Cas9 with a single guide RNA in cassava resulted in the emergence of a CRISPR-resistant virus strain (with a single conserved mutation) across three independent transgenic lines. We caution that CRISPR-induced virus evolution could have important implications for field studies using CRISPR-Cas9 to engineer plant virus immunity. The ability of CRISPR-systems to trigger the evolution of new viruses would also impact the regulatory mechanisms available for testing and releasing such plants. While the regulation of nontransgenic plants produced through CRISPR-Cas9-editing is being clarified in the US, Canada and the EU, the regulation of transgenic plants constitutively expressing Cas9 has not yet been considered. We expect that such plants will likely proceed under existing biosafety GMO regulations. However, our results point to a novel environmental containment consideration for regulating the release of plants constitutively expressing Cas9 and sgRNAs targeting a virus. We highly recommend sequencing the virus population in on-going studies utilizing CRISPR-Cas9 to engineer virus immunity in plants and animals. We also recommend testing whether using more efficient versions of Cas9, targeting multiple virus genes or using paired Cas9-nickases to delete larger portions of the viral genome can delay the emergence of resistant virus without enhancing recombination frequencies, which can participate in the emergence of hypervirulent geminivirus isolates 6, 16 .
Our findings lead us to conclude that strategies to use CRISPR-Cas9 to engineer virus resistance should be optimized to reduce the emergence of editing-resistant viruses. We have not yet tested the ability of the evolved virus to replicate independently. However, this mutant may also be an intermediate step towards the development of a truly pathogenic novel virus. One important feature of the CRISPR system in bacterial cells is its ability to adapt to invading DNA/RNA species. Further investigation into the mechanisms that underlie foreign DNA recognition and spacer acquisition by CRISPR systems in prokaryotes may result in the successful engineering of adaptive immunity to viruses in plants. In the meantime, the implementation of technologies with the potential to speed up virus evolution should be carefully assessed as they pose significant biosafety risks.
METHODS

Plasmid Cloning
The GoldenGate/MoClo system 17 was used to construct binary vectors for plant transformation. Level 1 plasmids bearing 35S promoter driven hptII (selectable marker) and plant codon optimised cas9-GFP genes were kindly provided by Dr Simon Bull (ETH Zurich). T7 promoterdriven sgRNA cassettes for in vitro expression were chemically synthesised (ThermoFisher) and blunt end cloned into a pJET1.2 vector (ThermoFisher)
sgRNA Design sgRNAs targeting the ACMV DNA A were designed using two parameters, cleavage efficiency and potential off-targets. Only sgRNAs with at least two seed sequence mismatches against the entire 750 Mb cassava genome were selected. First, high efficiency sgRNAs were obtained using published software from the Broad Institute, MIT 9 . The mismatch search included screening potential sgRNA targets in the cassava reference genome v6.1 (https://phytozome.jgi.doe.gov) with either the canonical NGG and non-canonical NAG protospacer-associated motifs (PAMs) for SpCas9. This yielded only 10 sgRNA designs (out of a total of 305 possible sgRNAs) meeting the off-target screening criteria, of which we selected the best six based on efficiency scores and target locations. These six sgRNAs ( Supplementary Fig. 1a) were further tested for effectiveness using an in vitro cleavage assay with purified Cas9/sgRNA complexes to cleave full-length AMCV amplicons ( Supplementary Fig. 1b) . We selected sgRNA1 for stable expression in transgenic cassava because it had the best predicted efficiency and performed well in the in vitro cleavage assay.
In vitro Transcription
T7::sgRNA expression cassettes were amplified from their respective pJET1.2 host vectors using primers listed in Supplementary Table 1. One µg of gel-purified linear DNA was used as a template in an in vitro transcription reaction using 100U of T7 RNA Polymerase (EP0111, ThermoFisher), 0.1U inorganic Pyrophosphatase (EF0221, ThermoFisher), 40U RiboLock RNase Inhibitor (EO0381, ThermoFisher) and 10mM NTP mix (R0481, ThermoFisher) in 1X T7 RNA Polymerase buffer for 16 hours at 37C. Transcribed sgRNAs were purified by Phenol:Chloroform extraction.
In vitro Cas9 cleavage assay
The in vitro Cas9 cleavage assay was performed according to a previously published protocol 18 . ACMV templates for cleavage were purified via PCR amplification from total DNA extracts of infected WT plant tissue using primers listed in Supplementary Table 1 . The purified GFP-tagged Cas9 endonuclease was kindly provided by Prof Martin Jinek (University of Zurich). Two hundred and fifty nano-grams of ACMV template DNA was digested with 1uM each of purified sgRNA and Cas9 protein. Digestion reactions were stopped at 15, 60 and 105 minutes. The in vitro cleavage assay to test resistance to the Cas9-sgRNA1 complex was similarly performed using a 409bp synthetic dsDNA template (Supplementary Data 2) designed from the ACMV-AC2 H54Q sequence.
Plant transformation and growth conditions
We generated cassava transgenic lines expressing the Cas9 protein together with sgRNA1 (referred to as Cas9+sgRNA1 lines) as well as control lines expressing only the Cas9 protein (referred to as Cas9 lines) using an established Agrobacterium tumefaciens-mediated transformation protocol 19 . Twenty transgenic cassava lines were characterized for T-DNA copy number ( Supplementary Fig. 7) and expression of the full-length, 180kDa GFP-tagged, plantcodon optimized Cas9 protein was verified via Western blotting (Supplementary Fig. 8 ). The selected lines expressed both the Cas9 and sgRNA transgenes at varying levels ( Supplementary  Fig. 1c,d ).
Agrobacterium mediated transformation of cassava variety 60444 was performed according to a previously published protocol. In vitro transformed cassava plantlets were grown at 28°C in a 16h photoperiod and sub-cultured at 4 week intervals in CBM media (1X Murashige-Skoog medium, 2% sucrose, 2µM copper sulphate, 0.3% gelrite, pH 5.8). 30 day-old plantlets were transferred to soil and grown in glasshouse conditions (14h photoperiod, 60% relative humidity, day/night temperatures: 26ºC/17ºC).
Southern Blotting for T-DNA integration analysis
Total DNA was extracted from leaves harvested from 4 week old in vitro grown plants using a modified CTAB (cetyl trimethylammonium bromide) protocol 20 . The same leaf samples were used for Western blots and Reverse Transcription-quantitative PCR (RT-qPCR) analysis. Ten µg of total DNA was restriction digested with 20U of HindIII (ThermoFisher) in an overnight reaction. The digested DNA was separated on a 0.8% agarose-TAE gel and transferred overnight onto a positively charged nylon membrane (Roti-Nylon Plus, Carl Roth). A 700bp probe against the hptII gene was PCR amplified from the binary vector and labelled with [α-32P] dCTP using the Prime-A-Gene kit (Promega). The nylon membrane was treated with PerfectHyb Plus Hybridization Buffer (Sigma-Aldrich) for 30 minutes followed by hybridisation together with the radio-labelled probe. Blots were developed using a Typhoon FLA 7500 imaging system (GE Healthcare Life Sciences).
Western Blotting
Crude protein extracts were prepared by incubating ground leaf tissue in a 5%SDS, 125mM Tris-HCL (pH6.8), 15%glycerol buffer with 1X EDTA-free Complete Protease Inhibitor (Roche) for 20 minutes at room temperature. Samples were centrifuged at 4C for 10 minutes to clear debris. Fifty µg of total protein extract were electrophoresed (after a 1:1 dilution with a bromophenol blue solution) on a pre-cast Novex 4-20% Tris-Glycine Midi gel (ThermoFisher) and transferred to a PVDF membrane (Carl Roth) using a TransBlot Cell (Bio-Rad) system according to the manufacturer's instructions. Membranes were blocked using a 5%milk and 1XTris buffered saline, 0.1%Tween20 (1XTBS-T) solution for 1 hour at room temperature. The blocked membrane was incubated in a primary blotting solution (1XTBS-T) with SpCas9 monoclonal (mouse) antibody (Diagenode) at a 1:2500 dilution and a polyclonal Actin (Rabbit) antibody (Agrisera) at a 1:1000 dilution for 1 hour at room temperature. After three 5 minute washes with 1XTBS-T, the membrane was incubated with a secondary blotting solution containing IRDye 800CW Goat antiMouse IgG and IRDye 680RD Goat anti-Rabbit IgG antibodies at a 1:5000 dilution each. Blots were imaged using the LICOR Odyssey CLx fluorescence imaging system. A PageRuler Prestained protein ladder (ThermoFisher) was used for size estimation.
Reverse Transcription-quantitative PCR 1.5ug of total RNA extract from leaf samples were DNase 1 treated and reverse transcribed with random hexamer primers using the Revert-Aid First strand cDNA synthesis kit (ThermoFisher) according to the manufacturer's instructions. Quantitative PCR was carried out with the Fast SYBR-Green dye for 40 cycles on a Lightcycler 480 instrument (Roche). Relative quantitation was performed using the MePP2A reference gene using the primers listed in Supplementary Table 1 .
Results of transgene-expression quantitation using RT-qPCR are presented in Supplementary  Fig. 1 c, d) 
Virus inoculation and symptom monitoring
Agrobacterium tumefaciens (strain LB4404) cells carrying infectious clones of ACMV-NOg DNA A and DNA B 7 were cultured for 48h at 28°C in 5 mL YEB broth (5 g/L tryptone, 1 g/L yeast extract, 5 g/L nutrient broth, 5 g/L sucrose, 2mM MgSO4) supplemented with antibiotics (25 mg/L rifampicin, 100 mg/L carbenicilin and 50 mg/L kanamycin). Two ml of the starter cultures were then individually added to 200 mL YEB medium with antibiotics and incubated overnight at 28°C to an OD600 of 0.6-1. Cells were pelleted by centrifuging at 5,000 x g for 10 min, then resuspended in 5 mL inoculation medium (10 mM MES pH 5.6, 10 mM MgCl2, 0.25 mM acetosyringone) and incubated for 2 hours at room temperature with shaking. DNA A and DNA B cultures at an OD600 of 2.0 were mixed in equal proportions prior to inoculation.
For inoculation, all leaves save the top leaf were removed from 6-week old cassava plantlets (65 plants in total). The stem and axillary buds were pricked prior to dipping the plantlets in Agrobacterium solution for 10 seconds and subsequently covered in a Plexiglas box for three days. A minimum of 5 inoculated plants per line were monitored for symptom incidence and severity over a period of 8 weeks. Symptoms in the top 3 leaves were scored weekly from 3 to 8-weeks post inoculation (wpi) on a scale of 0-3 as depicted in Supplementary Fig. 9 . The first emerging leaf from each plant was harvested 3 wpi. The top three leaves were harvested from each plant at 8 wpi.
Quantitation of virus titres
Virus quantitation was performed by relative quantification qPCR on 10ng of total DNA extracts using ACMV DNA A specific primers and MePP2A genomic DNA reference primers as listed in Supplementary Table 1 . Symptomatic leaves were harvested in three separate pools for each plant line (in the absence of symptomatic leaves, asymptomatic leaves were used). Three technical replicates were used per pooled sample. Results are shown in Supplementary Fig. 2c (8  wpi) and Supplementary Fig. 10 (3wpi) .
Single Molecule Real Time sequencing of viral amplicons
Full length viral amplicons from selected plant lines were prepared using target specific primers tailed with universal sequences (Supplementary Table 1 ) according to the protocol provided by Pacific Biosciences Inc. Equal amounts of each amplicon was used as a template in a second PCR using the Barcoded Universal Primers provided by Pacific Biosciences Inc. (Barcodes used per sample are listed in Supplementary Table 2) . The standard SMRTBell library construction protocol was used to prepare a pooled, barcoded, sequencing library. Sequencing was performed using a standard MagBead loading protocol on a PacBio RSII instrument. Polymerase reads were processed into barcode separated subreads by primary analysis on the instrument. The resulting subreads were processed using a standard ReadsOfInsert (ROI) analysis using SMRTPipe with a configuration file specifying a minimum ROI predicted quality of 99.9 and a minimum ROI length of 2600bp.
Sequence analysis
Sequences representing a near full-length region (2692bp) of the ACMV DNA A genome as well as a 100bp region surrounding the sgRNA target site were extracted from each ROI in order to maintain identical start and end sequence positions in each viral amplicon sequence read. Each resulting sequence was pairwise aligned (global alignment using NEEDLE parameters) against its corresponding reference ACMV-NOg DNA A sequence (GenBank: AJ427910). Pairwise alignment scores were assigned to each nucleotide as the sequence mismatch percentage of a 10-nucleotide window surrounding it. The resulting per-base score (y-axis) along each sequence read was plotted using the ggplot and ggjoy packages in R to produce Fig. 1a and Supplementary Fig.  3 . Total pairwise identity scores were used to create Supplementary Fig. 2d ,e. Background mismatches resulting from either sequencing errors or viral variants were found in all lines, including controls. We also failed to find any conserved edits on viruses infecting Cas9+sgRNA1 lines (and not control lines), indicating the absence of an off-target on the virus genome ( Supplementary Fig. 11 ). This was expected because the seed sequence of sgRNA1 does not have a close match to another site on the viral genome.
Code Availability
Python and R scripts used for sequence handling and graphical plotting are freely available at: http://www.github.com/hirschmm/CRISPR_amplicon-seq
Data Availability
Raw sequence data as well as alignment result files are available at: www.dx.doi.org/10.5281/zenodo.896915. The other raw datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request. 
